However, while in all AD patients, serum levels of BDNF were increased and Pro-BDNF decreased compared to controls, in ALS patients, the trend showed some differences, with only approximately 63% of cases displaying the same trend as AD, suggesting a certain heterogeneity degree. This evidence concerns the gene BDNF and Alzheimer disease.